South Africa lagging behind Rwanda in fight against HIV/AIDS
South Africa could learn valuable lessons from Rwanda's structural reforms that have prioritised education and healthcare - especially the fight against HIV/AIDS - as fundamental cornerstones of national policy, reports the local newspaper Business Day.
Rwanda is one of the world's poorest countries, with a gross domestic product (GDP) per capita of 1,150, according to statistics from the International Monetary Fund (IMF).
In comparison, South Africa's GDP per capita is 10,291, nine times bigger than that of Rwanda, according to the World Bank. Yet South Africa is lagging behind this tiny central African country in terms of achievements in education and the fight against HIV/AIDS.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze